The abstract is read at the publisher; the summary is JClub's.
Early-onset colorectal cancer (EOCRC) shows a tumor-immune microenvironment that is poorly characterized and may differ from later-onset (LOCRC) due to factors like tumor site, stage, and mismatch repair (MMR) status.
- Why it matters: Understanding EOCRC TiME is needed because age-related immune differences could be masked by confounding, limiting how well prevention and immune therapies can be tailored for younger patients.
- What they did: This review synthesizes evidence on EOCRC immune composition, functional states, and spatial organization, then links immunogenomic/epigenomic determinants (including MMR deficiency distribution and age-conditioned methylation) to neoantigen presentation and immune evasion.
- The result: The compiled findings are used to outline immune-based prevention approaches (risk stratification, screening, diet/microbiome interventions, chemoprevention) and immunotherapy strategies, especially checkpoint blockade and rational combinations in predominant microsatellite-stable EOCRC.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.